Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Thalassemia × Busulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 54 Leukemia 48 Myelodysplastic Syndromes 46 Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 23 Neoplasms, Plasma Cell 21 Congenital Abnormalities 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Burkitt Lymphoma 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Accelerated Phase 19 Blast Crisis 19 Myeloproliferative Disorders 18 Leukemia, Myeloid, Chronic-Phase 18 Primary Myelofibrosis 16 Hematologic Neoplasms 14 Graft vs Host Disease 13 Lymphoma, T-Cell, Cutaneous 12 Dendritic Cell Sarcoma, Interdigitating 12 Myelodysplastic-Myeloproliferative Diseases 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

fludarabine phosphate 2 Cyclophosphamide 2 fludarabine 1 Whole-Body Irradiation 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Busulfan 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡